Aptose Biosciences Inc. ("Aptose" or the "Company") , a clinical-stage precision oncology company developing a tuspetinib (TUS)-based triple drug frontline therapy to treat patients with newly ...

For the time being, passengers are able to fly either with a passport or by going through additional screening. Operations ...